Webcast

Share

Program Content

Activities

  • B-Cell BTKi Breakthroughs
    Breakthrough Therapeutics for CLL and Other B-Cell Malignancies: Focus on BTK Inhibitors From Development to Clinical Integration
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 31, 2023

    Expires: January 30, 2024

Faculty

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

cover img faculity

Ian W. Flinn, MD, PhD

Director
Lymphoma Research Program
Sarah Cannon Research Institute
Program Director
Sarah Cannon Center for Blood Cancer
Tennessee Oncology
Nashville, Tennessee

cover img faculity

Susan M. O'Brien, MD

Professor
Division of Hematology/Oncology
School of Medicine
University of California, Irvine
Orange, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

BeiGene, Ltd.

Lilly